Shopping Cart
Remove All
Your shopping cart is currently empty
Oloctinebart, a humanized immunoglobulin G4-kappa (IgG4-κ) monoclonal antibody targeting LGALS3, is utilized to decrease the formation of amyloid beta oligomers [1].

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $179 | - | In Stock | |
| 5 mg | $455 | - | In Stock | |
| 10 mg | $737 | - | In Stock | |
| 25 mg | $1,360 | - | In Stock | |
| 50 mg | $2,180 | - | In Stock |
| Description | Oloctinebart, a humanized immunoglobulin G4-kappa (IgG4-κ) monoclonal antibody targeting LGALS3, is utilized to decrease the formation of amyloid beta oligomers [1]. |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | LGALS3 |
| Molecular Weight | 144.88 kDa |
| Cas No. | 2669063-84-5 |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.